Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 12 de 12
Filter
1.
Rev Panam Salud Publica ; 25(4): 305-13, 2009 Apr.
Article in Spanish | MEDLINE | ID: mdl-19531318

ABSTRACT

OBJECTIVE: To examine the development of resistance to erythromycin, chloramphenicol, trimethoprim-sulfamethoxazole (TMP-SMZ), and vancomycin of the invasive isolates of Streptococcus pneumoniae obtained from children in 10 Latin American/Caribbean countries during six years of surveillance. METHODS: Analysis of 8 993 isolates of S. pneumoniae recovered in 2000-2005 from children with invasive infections, who were less than 6 years of age, and from Argentina, Brazil, Chile, Colombia, Cuba, Dominican Republic, Mexico, Paraguay, Uruguay, or Venezuela. Antibiotic susceptibility was determined through the methods established and standardized by the SIREVA project. Multidrug resistance was defined as: resistance to three or more antibiotics of the same class; to the non-beta-lactams analyzed by this study; or, to the beta-lactams evaluated by a previous study, in which 37.8% of these isolates showed decreased susceptibility to penicillin. RESULTS: Some degree of resistance was found to TMP-SMZ and erythromycin (56.4% and 15.4% of the isolates studied, respectively), with 4.6% highly resistant to chloramphenicol. All isolates were susceptible to vancomycin. The highest prevalence of TMP-SMZ resistance was observed in the pneumonia isolates; and that of erythromycin, in cases of sepsis (61.6% and 25.5%, respectively; P < 0.01). The highest prevalence of TMP-SMZ resistance was found in Brazil (71.9%), and that of erythromycin, in Mexico (38.2%) and Venezuela (32.9%). The 14, 6B, 19F, and 23F serotypes were most often associated with resistance to the antibiotics in the study. CONCLUSIONS: High and increasing rates of isolates resistant to TMP-SMZ and erythromycin were observed, as well as a decreasing percentage of isolates resistant to chloramphenicol. These trends highlight differences among the countries studied.


Subject(s)
Drug Resistance, Bacterial , Streptococcus pneumoniae/drug effects , Humans , Latin America , Microbial Sensitivity Tests
2.
Rev. panam. salud pública ; 25(4): 305-313, abr. 2009. graf, tab
Article in Spanish | LILACS | ID: lil-515969
3.
Rev Panam Salud Publica ; 25(4),abr. 2009 graf, tab
Article | PAHO-IRIS | ID: phr-9863
4.
Rev. cuba. med. trop ; 60(2)mayo-ago. 2008. tab
Article in Spanish | LILACS | ID: lil-506347

ABSTRACT

Objetivos: conocer la prevalencia de especies de enterococos causantes de infecciones en niño, su virulencia, susceptibilidad antimicrobiana e infecciones más frecuentes. Métodos: se estudiaron 156 aislamientos de enterococos causantes de infecciones en niños ingresados en el Hospital Octavio de la Concepción y La Pedraja, Holguín. Se llevó a cabo la identificación de especies y detección de factores de virulencia por métodos fenotípicos. Se determinó la concentración inhibitoria mínima para vancomicina, ciprofloxacina, ampicilina, gentamicina, estreptomicina, cloranfenicol, nitrofurantoína, eritromicina, tetraciclina, levofloxacina y norfloxacina, según las normas del Clinical Laboratory Standard Institute. Resultados: las cepas se aislaron de sangre, orina, heridas quirúrgicas, piel y tejido blando, oído medio, vulva, punta de catéter, líquido peritoneal, vagina, esperma, líquido cefalorraquídeo, y otras fuentes. La especie prevalente fue Enterococcus faecalis, seguido por Enterococcus faecium, Enterococcus gallinarum y Enterococcus raffinossus, Enterococcus casseliflavus y Enterococcus avium. La producción de proteasa y hemolisina se detectó solo en E. faecalis. E. faecium mostró porcentajes más altos de resistencia a ampicilina, ciprofloxacina, norfloxacina, levofloxacina, mientras que E. faecalis mostró más resistencia a eritromicina, cloranfenicol y tetraciclina. De E. faecalis 58 aislamientos y 12 de E. faecium presentaron altos niveles de resistencia a gentamicina, así como 45 y 32,3 por ciento mostraron altos niveles de resistencia para estreptomicina, respectivamente. Se detectó una cepa de E. faecium resistente a vancomicina. Conclusiones: la circulación de cepas de enterococos virulentas y resistentes a diferentes antibióticos indica la necesidad del control de la infección enterocócica...


Objectives: to find out the prevalence of Enterococcus species causing child infections, their virulence, antimicrobial susceptibility and most frequent infections. Methods: One hundred and fifty six isolations from Enterococcus causing infections in children, admitted to Octavio de la Concepción y La Pedraja hospital in Holguin, were studied. The phenotypical methods allowed identifying species and detecting virulence factors. Following Clinical Laboratory Standard Institute requirements, minimal inhibitory concentration was determined for vancomycin, ciprofloxacin, ampicilline, gentamycin, streptomycin, chloranphenicol, nitrofurantoine, erythromycin, tetracycline, levofloxacin and norfloxacine. Results: Strains were isolated from the blood, the urine, surgical wounds, the skin and the soft tissue, the middle ear, the vulva, catheter point, peritoneal fluid, vagina, sperm, cerebrospinal fluid, and from other sources. The prevailing species was Enterococcus faecalis followed by Enterococcus faecium, Enterococcus gallinarum y Enterococcus raffinossus, Enterococcus casseliflavus y Enterococcus avium. Protease and hemolysin was only detected in E. faecalis. E. faecium accounted for the highest percentage of resistance to ampicillin, ciprofloxacine, norfloxacin, levofloxacin whereas E. faecalis was more resistant to erythromycin, chloranphenicol and tetracycline. Fifty eight E. faecalis isolates and 12 E. faecium isolates exhibited the highest levels of resistance to gentamycin, as well as 45 percent and 32.3 percent of samples had high levels of resistance to streptomycin respectively. A vancomycin-resistent E. faecium strain was detected. Conclusions: The circulation of virulent and multiple resistant Enterococcus strains indicates that Enterococcus infection need to be controlled and the importance of monitoring antimicrobial susceptibility...


Subject(s)
Humans , Child , Adolescent , Enterococcus/virology , Cross Infection/complications , Microbial Sensitivity Tests/methods , Cuba , Epidemiology, Descriptive , Retrospective Studies
5.
Rev. cuba. med. trop ; 60(2)Mayo-ago. 2008. tab
Article in Spanish | CUMED | ID: cum-37405

ABSTRACT

Objetivos: conocer la prevalencia de especies de enterococos causantes de infecciones en niño, su virulencia, susceptibilidad antimicrobiana e infecciones más frecuentes. Métodos: se estudiaron 156 aislamientos de enterococos causantes de infecciones en niños ingresados en el Hospital Octavio de la Concepción y La Pedraja, Holguín. Se llevó a cabo la identificación de especies y detección de factores de virulencia por métodos fenotípicos. Se determinó la concentración inhibitoria mínima para vancomicina, ciprofloxacina, ampicilina, gentamicina, estreptomicina, cloranfenicol, nitrofurantoína, eritromicina, tetraciclina, levofloxacina y norfloxacina, según las normas del Clinical Laboratory Standard Institute. Resultados: las cepas se aislaron de sangre, orina, heridas quirúrgicas, piel y tejido blando, oído medio, vulva, punta de catéter, líquido peritoneal, vagina, esperma, líquido cefalorraquídeo, y otras fuentes. La especie prevalente fue Enterococcus faecalis, seguido por Enterococcus faecium, Enterococcus gallinarum y Enterococcus raffinossus, Enterococcus casseliflavus y Enterococcus avium. La producción de proteasa y hemolisina se detectó solo en E. faecalis. E. faecium mostró porcentajes más altos de resistencia a ampicilina, ciprofloxacina, norfloxacina, levofloxacina, mientras que E. faecalis mostró más resistencia a eritromicina, cloranfenicol y tetraciclina. De E. faecalis 58 aislamientos y 12 de E. faecium presentaron altos niveles de resistencia a gentamicina, así como 45 y 32,3 por ciento mostraron altos niveles de resistencia para estreptomicina, respectivamente. Se detectó una cepa de E. faecium resistente a vancomicina. Conclusiones: la circulación de cepas de enterococos virulentas y resistentes a diferentes antibióticos indica la necesidad del control de la infección enterocócica..........(AU)


Objectives: to find out the prevalence of Enterococcus species causing child infections, their virulence, antimicrobial susceptibility and most frequent infections. Methods: One hundred and fifty six isolations from Enterococcus causing infections in children, admitted to Octavio de la Concepción y La Pedraja hospital in Holguin, were studied. The phenotypical methods allowed identifying species and detecting virulence factors. Following Clinical Laboratory Standard Institute requirements, minimal inhibitory concentration was determined for vancomycin, ciprofloxacin, ampicilline, gentamycin, streptomycin, chloranphenicol, nitrofurantoine, erythromycin, tetracycline, levofloxacin and norfloxacine. Results: Strains were isolated from the blood, the urine, surgical wounds, the skin and the soft tissue, the middle ear, the vulva, catheter point, peritoneal fluid, vagina, sperm, cerebrospinal fluid, and from other sources. The prevailing species was Enterococcus faecalis followed by Enterococcus faecium, Enterococcus gallinarum y Enterococcus raffinossus, Enterococcus casseliflavus y Enterococcus avium. Protease and hemolysin was only detected in E. faecalis. E. faecium accounted for the highest percentage of resistance to ampicillin, ciprofloxacine, norfloxacin, levofloxacin whereas E. faecalis was more resistant to erythromycin, chloranphenicol and tetracycline. Fifty eight E. faecalis isolates and 12 E. faecium isolates exhibited the highest levels of resistance to gentamycin, as well as 45 percent and 32.3 percent of samples had high levels of resistance to streptomycin respectively. A vancomycin-resistent E. faecium strain was detected. Conclusions: The circulation of virulent and multiple resistant Enterococcus strains indicates that Enterococcus infection need to be controlled and the importance of monitoring antimicrobial susceptibility ....................(AU)


Subject(s)
Humans , Child , Adolescent , Enterococcus/virology , Microbial Sensitivity Tests/methods , Cross Infection/complications , Epidemiology, Descriptive , Retrospective Studies , Cuba
6.
Biotechnol Appl Biochem ; 44(Pt 2): 101-8, 2006 May.
Article in English | MEDLINE | ID: mdl-16420190

ABSTRACT

A simple, specific, sensitive and reproducible ELISA has been developed to quantify the level of CPS (capsular polysaccharide) production in supernatants of Streptococcus pneumoniae cell cultures. CPSs from Strep. pneumoniae have been widely used as vaccine antigens. The quantification method is based on two type-23F serotype-specific polyclonal antibodies: IgG, purified from sera of mice immunized with a pneumococcal type-23F CPS conjugate, used in the coating step, and a serotype-specific rabbit serum as the second antibody. Solutions of purified type-23F CPS were used as standards. The relationship between A(492) and type-23F CPS concentration was linear over the range 1-310 ng/ml (r=0.989), with 1 ng/ml as the lower limit of sensitivity. The specificity of ELISA was assessed because purified type-19F CPS and cell-wall polysaccharide samples were not detected after their evaluation by the ELISA described in the present study. Repeatability and intermediate precision of the assay were good, the coefficients of variation being 3 and 10% respectively. This ELISA allowed selection of an appropriate vaccine strain, for a natural polysaccharide vaccine, among several 23F pneumococcal clinical isolates and constituted a valuable analytical tool for Strep. pneumoniae fermentation and CPS purification follow-up.


Subject(s)
Bacterial Capsules/chemistry , Enzyme-Linked Immunosorbent Assay/methods , Meningitis, Pneumococcal/diagnosis , Polysaccharides, Bacterial/analysis , Streptococcus pneumoniae/classification , Animals , Bacterial Capsules/biosynthesis , Child, Preschool , Female , Humans , Infant , Infant, Newborn , Mice , Mice, Inbred BALB C , Polysaccharides, Bacterial/biosynthesis , Polysaccharides, Bacterial/isolation & purification , Reproducibility of Results , Streptococcus pneumoniae/metabolism
7.
J Antimicrob Chemother ; 52(4): 695-8, 2003 Oct.
Article in English | MEDLINE | ID: mdl-12951346

ABSTRACT

OBJECTIVES: A national surveillance study to determine antimicrobial susceptibility in Haemophilus influenzae type b isolated from cerebrospinal fluid was carried out in Cuba from 1990 to 2002. METHODS: Susceptibility to ampicillin, co-amoxiclav, cefotaxime, ceftriaxone, co-trimoxazole, tetracycline, chloramphenicol and rifampicin was tested by the microdilution method according to the NCCLS guidelines. RESULTS: The 34 participating laboratories recovered 938 consecutive, non-identical isolates. All the isolates were retrieved from children aged <5 years. The mean number of isolates collected by year in the pre-vaccination era (1990-1998) was 93; after vaccination, 57 isolates were reported in 1999, 31 in 2000, four in 2001 and five in 2002. Resistance to ampicillin, co-trimoxazole, tetracycline and chloramphenicol was 46.3% (all beta-lactamase-positive), 51.3%, 33.2% and 44.0%, respectively. Ampicillin-resistant beta-lactamase-negative strains were not detected. All strains were susceptible to co-amoxiclav, cefotaxime, ceftriaxone and rifampicin. Ampicillin resistance was strongly associated with resistance to tetracycline, co-trimoxazole and chloramphenicol (P<0.001). Multidrug resistance was present in 43.8% of isolates. The most prevalent phenotype was resistance to ampicillin/chloramphenicol/tetracycline/co-trimoxazole, which was detected in 29.2% of strains overall. An increase in the prevalence of resistance to these antibiotics was observed from 1990 to 2000 in the range 40.7%-54.8% for ampicillin, 40.1%-51.6% for chloramphenicol, 45.4%-58.1% for co-trimoxazole and 23%-45.2% for tetracycline. CONCLUSIONS: In Cuba, the widespread vaccination against Haemophilus influenzae type b prevented a large number of meningitis cases in children caused by strains resistant to multiple antibiotics.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Drug Resistance, Multiple, Bacterial/drug effects , Haemophilus influenzae type b/drug effects , Meningitis, Haemophilus/drug therapy , Anti-Bacterial Agents/pharmacology , Chi-Square Distribution , Child, Preschool , Confidence Intervals , Cuba/epidemiology , Drug Resistance, Multiple, Bacterial/physiology , Haemophilus influenzae type b/growth & development , Humans , Meningitis, Haemophilus/epidemiology , Microbial Sensitivity Tests/methods , Microbial Sensitivity Tests/trends , Odds Ratio
8.
Biotecnol apl ; 20(2)abr.-Jun. 2003. graf
Article in Spanish | CUMED | ID: cum-38651

ABSTRACT

Objetivos: Desde 1998 se implementó en Cuba un nuevo sistema de vigilancia nacional de meningitis bacteriana (VNMB) con el objetivo de lograr información en correspondencia con el desarrollo científico actual y las exigencias del programa nacional de prevención y control de estas infecciones. Resultados: Este sistema permitió medir el impacto de la vacuna contra H. influenzae tipo b (Hib) en 1999 sin necesidad de un proyecto y gastos adicionales, demostrando la reducción inmediata de la incidencia (52por ciento). Hasta el 2002 fueron reportados 82 niños < 5 años de los cuales 61(74,4por ciento) no estaban vacunados. Entre los vacunados hubo 14 (66,7por ciento) con una sola dosis aplicada.A partir de esta intervención S. pneumoniae resultó el principal agente causal de meningitis. Los serogrupos/ serotipos más frecuentes han sido 19, 6, 14, 18, 1, 7 y 23, mostrando un 40por ciento de susceptibilidad disminuida a la penicilina. Por primera vez identificamos: - fuerte asociación (RR > 20) de los estudiantes internos de primaria con la enfermedad, - incidencia elevada entre amas de casa (> 2/100 000) y jubilados (> 8/100 000), - fuerte asociación (Razón de disparidad > 20) de la muerte con jubilados y amas de casa en el análisis multivariado. Los resultados microbiológicos posibilitaron la caracterización de agentes y la política antibiótica más adecuada. La letalidad general de la meningitis neumocócica fue > 32 por ciento y fundamentalmente en ancianos. Conclusiones: LaVNMB aportó novedosa información clínico - epidemiológica y microbiológica, permitiendo ampliar el marco integral de los conocimientos y garantizando acciones más efectivas y eficientes en un proyecto multidisciplinario e intersectorial generalizado (AU)


Subject(s)
Humans , Male , Female , Meningitis, Bacterial/epidemiology , Meningitis/epidemiology
9.
Article in Es | IBECS | ID: ibc-2963

ABSTRACT

FUNDAMENTO. Recientes pero escasos informes de cepas de Staphylococcuss aureus resistentes a la meticilina (SARM) entre niños no expuestos a los factores de riesgos asociados con su adquisición, nos indujeron a investigar su circulación en la comunidad. PACIENTES Y MÉTODOS. Durante los meses de septiembre y octubre de 1997 se tomaron exudados nasales y faríngeos a 358 niños menores de 5 años, atendidos en tres círculos infantiles del municipio Marianao de la Ciudad de La Habana, Cuba. Las cepas de S. aureus aisladas fueron caracterizadas por susceptibilidad a antimicrobianos utilizando el método de Kirby-Bauer. Se confirmó la resistencia a la meticilina a través del método " Oxacillin Salt-Agar Screening-Plate" recomendado por el Comité Nacional de Procedimientos Estándar del Laboratorio Clínico. RESULTADOS. El 18,7 por ciento de los niños portaban cepas de S. aureus en el tracto respiratorio superior. En el 2,2 por ciento eran cepas de SARM. Los índices más altos de resistencia se revelaron para la eritromicina (50,7 por ciento) y tetraciclina (29,9 por ciento). Todas las cepas fueron susceptibles a la ciprofloxacina. CONCLUSIONES. Nuestros resultados proporcionan evidencias sobre el aislamiento de cepas de SARM entre niños sanos atendidos en círculos infantiles, e indican la posibilidad de que éstas se establezcan y diseminen de forma acelerada en la comunidad (AU)


Subject(s)
Child, Preschool , Male , Female , Humans , Methicillin Resistance , Staphylococcus aureus , Staphylococcal Infections , Nose , Child Day Care Centers , Child Care , Cuba
12.
Managua; Organización Panamericana de la Salud/Organización Mundial de la Salud; dic. 1995. 6 p.
Monography in Spanish | LILACS | ID: lil-180408
SELECTION OF CITATIONS
SEARCH DETAIL
...